Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Amgen (NASDAQ:AMGN) Secures FDA Clearance for IMDELLTRA After Phase 3 Success

Amgen (NASDAQ:AMGN) has received full approval from the U.S.Food and Drug Administrationfor IMDELLTRA (tarlatamab-dlle), a targeted therapy for adults with extensive-stage small cell lung cancer (ES-SCLC) whose disease has progressed on or after platinum-based chemotherapy. This decision upgrades IMDELLTRA’s initial accelerated approval, marking a …

Team Kalkine | 20 November 2025

DA Davidson Reiterates Buy Rating on Cars.com (NYSE:CARS)

DA Davidson has reiterated its Buy rating on Cars.com (NYSE:CARS). The firm also maintained a target price of USD 13.50. The latest research note was shared with investors on Tuesday. The update reflects the brokerage’s assessment based on recent operating performance and industry conditions.

Aditi Sarkar | 19 November 2025

Gilead (Nasdaq:GILD) Lenacapavir Arrives in Eswatini and Zambia in Major HIV Prevention Milestone

Gilead Sciences, Inc. (Nasdaq:GILD) has taken a crucial step in global HIV prevention with the first deliveries of its twice-yearly injectable PrEP medicine, lenacapavir, to Eswatini and Zambia. These shipments signify an important moment for communities in sub-Saharan Africa, a region that accounts for …

Team Kalkine | 19 November 2025

eBay (NASDAQ:EBAY) Global Recommerce Momentum Builds as Younger Shoppers Lead the Shift

eBay Inc. (NASDAQ:EBAY) has released its fifth annual Recommerce Report, revealing a significant shift in global consumer behavior toward pre-loved goods. According to the research, 89% of respondents worldwide expect to spend the same or more on pre-loved items in 2025 compared to 2024. …

Team Kalkine | 19 November 2025

Allegiant (NASDAQ:ALGT) Airline Enters Four New Markets With Major 2026 Route Launch

Allegiant Travel Company (NASDAQ:ALGT) has unveiled a major expansion of its national route network, announcing 30 new nonstop routes across 35 cities in the United States. This development includes the airline’s entry into four new markets: La Crosse in Wisconsin, Trenton in New Jersey, …

Team Kalkine | 19 November 2025

Zymeworks (Nasdaq:ZYME) Strategic Initiative Targets Expansion of Revenue-Generating Healthcare Assets

Zymeworks Inc. (Nasdaq:ZYME) has launched a strategic initiative designed to maximize long-term value from its growing roster of licensed biotherapeutics and healthcare assets. This decision follows encouraging developments across key programs, including positive topline data from the pivotal Phase 3 HERIZON-GEA-01 trial for Ziihera …

Team Kalkine | 19 November 2025

AerCap (NYSE:AER) FlySafair Secures Five Boeing Jets Under New Leasing Partnership

AerCap Holdings N.V., (NYSE:AER), one of the world’s leading aviation leasing companies, has entered into a new agreement with FlySafair for the lease of five Boeing aircraft—three new Boeing 737 MAX 8 jets and two Boeing 737-800NG aircraft. Announced at the Dubai Airshow 2025, …

Team Kalkine | 19 November 2025

AkzoNobel and Axalta (NYSE:AXTA) Strategic Merger Sets Stage for New Innovation-Driven Coatings Giant

Axalta (NYSE:AXTA) and AkzoNobel have entered into a definitive agreement to merge in an all-stock transaction, forming a coatings powerhouse with anenterprise valueof approximately USD 25 billion. Themergedcompany will bring together two long-respected players with complementary strengths across decorative paints, industrial coatings, mobility applications, …

Team Kalkine | 19 November 2025

Omdia (NASDAQ:TTGT) Market Competition Intensifies Amid 3Q25 Smartphone Shipment Drop

Southeast Asia’s smartphone market saw a marginal 1% year-on-year decline in 3Q25, with shipments totaling 25.6 million units, according to Omdia’s(NASDAQ:TTGT)latest findings. This marks the third consecutive quarter of contraction, underscoring continued consumer caution and intense competition in a region where more than 60% …

Team Kalkine | 19 November 2025

Stabilizing Futures, Mixed Earnings, and Shifting Macro Signals

Market Movers:On Tuesday, the top gainers were Olema Pharmaceuticals, Inc. (+136.38%), followed by Epsium Enterprise Limited (+91.55%). On the contrary SMX (Security Matters) Public Limited Company (-37.14%), and HCW Biologics Inc. (-21.24%) declined the most the same day.

Team Kalkine | 19 November 2025